Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weichenthal

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
Photodermatology, Photoimmunology & Photomedicine|September 10, 2005
Phototherapy: how does UV work?Michael Weichenthal, Thomas Schwarz
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 24, 2016
NachrufEnno Christophers, Michael Weichenthal
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 5, 2008
[Therapy of cutaneous T-cell lymphoma]Chalif Assaf, Michael Weichenthal
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 9, 2014
[ADOReg -- registry of the Scientific Work Group on Dermatological Oncology]Ulrike Leiter Tübingen, Michael Weichenthal Kiel
The Journal of Investigative Dermatology|September 18, 2004
Resistance of human melanoma cells against the death ligand TRAIL is reversed by ultraviolet-B radiation via downregulation of FLIPElke Zeise, Michael Weichenthal, Thomas Schwarz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2021
Rare haematologic and neurologic drug reactions from immune checkpoint inhibition in a responding patient with metastatic anorectal mucosal melanomaSarah Qaiyumi, Wolfram Klapper, Axel Hauschild, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanomaPeter Mohr, Axel Hauschild, Uwe Trefzer, et al.
Melanoma Research|December 24, 2008
Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapseFriederike Egberts, Wolfgang N Hitschler, Michael Weichenthal, et al.
Onkologie|December 14, 2004
Malignant melanoma and HIV infection -- aggressive course despite immune reconstitutionChristian Hoffmann, Heinz-August Horst, Michael Weichenthal, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 30, 2016
Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune DiseaseLara V Maul, Michael Weichenthal, Katharina C Kähler, et al.
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
Photodermatology, Photoimmunology & Photomedicine|September 10, 2005
Phototherapy: how does UV work?Michael Weichenthal, Thomas Schwarz
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 24, 2016
NachrufEnno Christophers, Michael Weichenthal
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 5, 2008
[Therapy of cutaneous T-cell lymphoma]Chalif Assaf, Michael Weichenthal
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 9, 2014
[ADOReg -- registry of the Scientific Work Group on Dermatological Oncology]Ulrike Leiter Tübingen, Michael Weichenthal Kiel
The Journal of Investigative Dermatology|September 18, 2004
Resistance of human melanoma cells against the death ligand TRAIL is reversed by ultraviolet-B radiation via downregulation of FLIPElke Zeise, Michael Weichenthal, Thomas Schwarz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2021
Rare haematologic and neurologic drug reactions from immune checkpoint inhibition in a responding patient with metastatic anorectal mucosal melanomaSarah Qaiyumi, Wolfram Klapper, Axel Hauschild, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanomaPeter Mohr, Axel Hauschild, Uwe Trefzer, et al.
Melanoma Research|December 24, 2008
Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapseFriederike Egberts, Wolfgang N Hitschler, Michael Weichenthal, et al.
Onkologie|December 14, 2004
Malignant melanoma and HIV infection -- aggressive course despite immune reconstitutionChristian Hoffmann, Heinz-August Horst, Michael Weichenthal, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 30, 2016
Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune DiseaseLara V Maul, Michael Weichenthal, Katharina C Kähler, et al.
Pageof 17